Trials / Conditions / Adult Rhabdomyosarcoma

Adult Rhabdomyosarcoma

17 registered clinical trials studyying Adult Rhabdomyosarcoma.

Status	Trial	Sponsor	Phase
Completed	Biomarkers in Patients With Advanced Rhabdomyosarcoma NCT01668095	Children's Oncology Group	—
Completed	Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma NCT01532687	OHSU Knight Cancer Institute	Phase 2
Completed	Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases NCT01586104	Ann & Robert H Lurie Children's Hospital of Chicago	N/A
Completed	Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients NCT01222715	National Cancer Institute (NCI)	Phase 2
Completed	Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced NCT01154452	National Cancer Institute (NCI)	Phase 1 / Phase 2
Completed	Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma NCT01055314	National Cancer Institute (NCI)	Phase 2
Completed	Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors NCT00831844	National Cancer Institute (NCI)	Phase 2
Completed	Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metasta NCT00720174	National Cancer Institute (NCI)	Phase 1
Completed	AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma NCT00659360	National Cancer Institute (NCI)	Phase 2
Completed	Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagn NCT00638898	City of Hope Medical Center	Phase 1
Completed	Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma NCT00354835	Children's Oncology Group	Phase 3
Completed	Ixabepilone in Treating Young Patients With Refractory Solid Tumors NCT00331643	National Cancer Institute (NCI)	Phase 2
Completed	Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma NCT00112463	National Cancer Institute (NCI)	Phase 2
Completed	Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Ne NCT00075582	Children's Oncology Group	Phase 3
Completed	Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma NCT00003958	Children's Oncology Group	Phase 3
Completed	Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Sof NCT00919269	Children's Oncology Group	—
Terminated	S9624 Ifosfamide in Treating Patients With Meningeal Tumors NCT00003292	SWOG Cancer Research Network	Phase 2